ArticleIn silico pharmacology2024

Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies.

Khalifa Sunusi Aminu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.